TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33530704

Group type: EXPERIMENTAL
Intervention: Sacubitril/Valsartan
Number of subjects: 881

Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 881
Study: 32917231

Group type: EXPERIMENTAL
Intervention: BDCPP
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: DPHP
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: BCEP
Number of subjects: 56
Study: 34536136

Group type: EXPERIMENTAL
Intervention: Enamel matrix derivative (EMD)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control (no EMD)
Number of subjects: 32
Study: 36294019

Group type: EXPERIMENTAL
Intervention: Nutrition Counselling (NC)
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Nutrition Counselling (NC) + Unconditional Cash Transfer (UCT)
Number of subjects: 255

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 255
Study: 33693782

Group type: EXPERIMENTAL
Intervention: Changes in physical activity (PA)
Number of subjects: 489

Group type: EXPERIMENTAL
Intervention: Changes in adherence to the Mediterranean diet (MedDiet)
Number of subjects: 489
Study: 35756958

Group type: EXPERIMENTAL
Intervention: Unaltered base attachment (UA)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Custom base attachment (CBA)
Number of subjects: 6
Study: 35247960

Group type: EXPERIMENTAL
Intervention: Peer mentorship (weekly telephone calls with trained mentors for 3 months)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 200
Study: 34217844

Group type: EXPERIMENTAL
Intervention: Dietary Astragalus Propinquus schischkin polysaccharides (1000 mg/kg)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Dietary Astragalus Propinquus schischkin polysaccharides (various dosages including 1000 mg/kg)
Number of subjects: 5
Study: 32306935

Group type: EXPERIMENTAL
Intervention: Cognitive‐behavioural group therapy (CBGT)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Mindfulness‐based stress reduction (MBSR)
Number of subjects: 125
Study: 35916003

Group type: EXPERIMENTAL
Intervention: Channel-cleaning ball brush (BB)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Conventional brush (CB)
Number of subjects: 114
Study: 32711724

Group type: EXPERIMENTAL
Intervention: Personalised haemodynamic management targeting baseline cardiac index
Number of subjects: 188

Group type: COMPARATOR
Intervention: Routine management
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Personalised haemodynamic management
Number of subjects: 188
Study: 34533410

Group type: EXPERIMENTAL
Intervention: Sublingual oestradiol hemihydrate (1.3 mg/day) for 12 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Sublingual oestradiol hemihydrate (1.3 mg/day)
Number of subjects: 30
Study: 35753879

Group type: EXPERIMENTAL
Intervention: TLH-CTM
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: TAH-CTM
Number of subjects: 60

Group type: COMPARATOR
Intervention: TLH control
Number of subjects: 60

Group type: COMPARATOR
Intervention: TAH control
Number of subjects: 60
Study: 33096222

Group type: EXPERIMENTAL
Intervention: Intervention group (short instructions alongside peer reviewers’ comments)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group (usual peer-review process)
Number of subjects: 108
Study: 32787416

Group type: EXPERIMENTAL
Intervention: Academic education in CLP and CFD
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Professional services offered by SLTs
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Need for improvement in academic education
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Recommendations for educational improvement
Number of subjects: 123
Study: 34502202

Group type: EXPERIMENTAL
Intervention: Low-intensity extracorporeal shock wave therapy (LiESWT) at 0.25 mJ/mm2, 3000 pulses, 3 pulses/second
Number of subjects: 58
Study: 34753612

Group type: EXPERIMENTAL
Intervention: self‐directed web‐based stress management program (n = 30)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: web‐based stress management program plus lay telephone coaching (n = 29)
Number of subjects: 59

Group type: COMPARATOR
Intervention: motivational interviewing (MI)
Number of subjects: 59
Study: 32761276

Group type: EXPERIMENTAL
Intervention: Patellar denervation (PD)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Non-denervation group
Number of subjects: 202
Study: 32448017

Group type: EXPERIMENTAL
Intervention: Intradialytic Resistance Training (IRT) for 12 weeks
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (CNG) - physically inactive during hemodialysis
Number of subjects: 90
Study: 32326664

Group type: EXPERIMENTAL
Intervention: Ubiquinol 200 mg/day
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Ubiquinol 100 mg/day
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Ubiquinol (both doses)
Number of subjects: 51
Study: 35737551

Group type: EXPERIMENTAL
Intervention: Nonalcohol EFT conditions
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: EFT content around professional work
Number of subjects: 360

Group type: COMPARATOR
Intervention: Alcohol EFT conditions
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: EFT valence
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: EFT
Number of subjects: 360
Study: 34444573

Group type: EXPERIMENTAL
Intervention: Dietary and physical activity interventions group (DPG; mobile phone with the App and bracelet)
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: Physical activity interventions group (PG; mobile phone with the App and bracelet)
Number of subjects: 750

Group type: COMPARATOR
Intervention: Control group (CG; no interventions)
Number of subjects: 750
Study: 32195903

Group type: EXPERIMENTAL
Intervention: Electronic version of the Pediatric Index of Mortality 2 score
Number of subjects: 12582

Group type: COMPARATOR
Intervention: Manually ascertained Pediatric Index of Mortality 2 score
Number of subjects: 12582
Study: 36001991

Group type: EXPERIMENTAL
Intervention: Residual Angina (RA) at 1 year post-revascularization
Number of subjects: 1428

Group type: COMPARATOR
Intervention: No Residual Angina (no-RA) at 1 year post-revascularization
Number of subjects: 1428
Study: 34800398

Group type: EXPERIMENTAL
Intervention: Teriflunomide (14 mg equivalent in adults)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Teriflunomide
Number of subjects: 166
Study: 35709600

Group type: EXPERIMENTAL
Intervention: Enzalutamide (160 mg daily)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Abiraterone acetate plus prednisone (1000 mg abiraterone acetate and 10 mg prednisone daily)
Number of subjects: 170
Study: 32947028

Group type: EXPERIMENTAL
Intervention: Aminolevulinic acid/photodynamic therapy
Number of subjects: 269

Group type: COMPARATOR
Intervention: Vehicle/photodynamic therapy
Number of subjects: 269
Study: 33858390

Group type: EXPERIMENTAL
Intervention: Standard Hemodialysis (HD)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: HD with cooled dialysate
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Low-volume HDF
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: High-volume HDF (HV-HDF)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: All modalities
Number of subjects: 40
Study: 33370247

Group type: EXPERIMENTAL
Intervention: Topical oxygen continuously diffused to DFU tissue
Number of subjects: 0

Group type: COMPARATOR
Intervention: Continuously diffused topical oxygen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen (HBO) therapy
Number of subjects: 0
Study: 33175316

Group type: EXPERIMENTAL
Intervention: Brimonidine tartrate 0.2% ophthalmic solution
Number of subjects: 59

Group type: COMPARATOR
Intervention: Artificial tears (control)
Number of subjects: 59
Study: 34256588

Group type: EXPERIMENTAL
Intervention: Fetal bovine acellular dermal matrix (FBADM) plus standard of care (SOC)
Number of subjects: 207

Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 207
Study: 33213440

Group type: EXPERIMENTAL
Intervention: Biodentine
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Endocem MTA
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: ProRoot MTA
Number of subjects: 42
Study: 34958762

Group type: EXPERIMENTAL
Intervention: Corticosteroids plus hyaluronic acid (HA)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Hyaluronic acid (HA) alone
Number of subjects: 57
Study: 34011181

Group type: EXPERIMENTAL
Intervention: Patients with low level of symptoms on all outcomes
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: Patients with high psychotic symptoms
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: Patients with high anxio-depressive symptoms
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: Patients with elevated substance abuse and high levels of symptoms on all scales
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: Childhood abuse (CA)
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: Externalizing behaviors (EB)
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: Sex
Number of subjects: 402

Group type: COMPARATOR
Intervention: Comparison group of 92 healthy participants
Number of subjects: 402
Study: 32051551

Group type: EXPERIMENTAL
Intervention: Primary focal therapy (HIFU or cryotherapy)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Routine implementation of mpMRI
Number of subjects: 0
Study: 35149036

Group type: EXPERIMENTAL
Intervention: Monotherapy with edoxaban (a non-vitamin K antagonist oral anticoagulant)
Number of subjects: 1038

Group type: COMPARATOR
Intervention: Combination therapy with edoxaban plus a single antiplatelet agent
Number of subjects: 1038
Study: 32556194

Group type: EXPERIMENTAL
Intervention: Azithromycin (5-day course)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 34843839

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin administration
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo administration
Number of subjects: 58
Study: 32330925

Group type: EXPERIMENTAL
Intervention: 5‐HT depletion
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: DA depletion
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 36373820

Group type: EXPERIMENTAL
Intervention: 5 g/day NWT-03
Number of subjects: 76

Group type: COMPARATOR
Intervention: 5 g/day maltodextrin
Number of subjects: 76
Study: 33537760

Group type: EXPERIMENTAL
Intervention: BCAA supplementation at 0.1 g · kg‐1 body weight · d‐1
Number of subjects: 132

Group type: COMPARATOR
Intervention: Standard-protein diet with placebo (control, CT)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: High-protein diet with placebo (HP)
Number of subjects: 132
Study: 32515040

Group type: EXPERIMENTAL
Intervention: Aloe sterol
Number of subjects: 122

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122
Study: 34348753

Group type: EXPERIMENTAL
Intervention: Femoral Neck System (FNS)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Triple Screw construct (TS)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Dynamic Hip Screw system (DHS)
Number of subjects: 63
Study: 35872150

Group type: EXPERIMENTAL
Intervention: Sleep extension condition (instructed to increase sleep opportunity by 90 minutes)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Sleep as usual condition (control group)
Number of subjects: 72
Study: 33988954

Group type: EXPERIMENTAL
Intervention: Shoulder rotation position
Number of subjects: 40

Group type: COMPARATOR
Intervention: Lateral decubitus position
Number of subjects: 40
Study: 32128634

Group type: EXPERIMENTAL
Intervention: Trifluridine/tipiracil (35 mg/m2 twice daily on days 1-5 and 8-12 of each 28-day cycle) plus best supportive care (BSC)
Number of subjects: 507

Group type: COMPARATOR
Intervention: Placebo plus best supportive care (BSC)
Number of subjects: 507
Study: 33837916

Group type: COMPARATOR
Intervention: Home sleep monitoring (H)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Laboratory sleep monitoring (L)
Number of subjects: 40
Study: 32606078

Group type: EXPERIMENTAL
Intervention: Pattern Scanning Laser Trabeculoplasty (PSLT)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Selective Laser Trabeculoplasty (SLT)
Number of subjects: 132
Study: 34346852

Group type: EXPERIMENTAL
Intervention: Electroconvulsive therapy (ECT) data from the Swedish national quality register (Q‐ECT)
Number of subjects: 200
Study: 34637142

Group type: EXPERIMENTAL
Intervention: Tralokinumab
Number of subjects: 2285

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2285
Study: 36364794

Group type: EXPERIMENTAL
Intervention: Skim milk (MILK)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Carbohydrate drink (CHO)
Number of subjects: 13
Study: 32929647

Group type: EXPERIMENTAL
Intervention: HCV therapy (interferon-based therapy or interferon-free therapy); duration of treatment not specified, but monitoring period is 6 months for cirrhosis patients and 3 months for non-cirrhosis patients.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HCV therapy (treated cohort)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Untreated cohort (therapy-naïve patients)
Number of subjects: 0
Study: 32519327

Group type: EXPERIMENTAL
Intervention: Video presentation
Number of subjects: 37

Group type: COMPARATOR
Intervention: Conventional educational leaflets and verbal instructions
Number of subjects: 37
Study: 33798986

Group type: EXPERIMENTAL
Intervention: iLearning app for chest tube care
Number of subjects: 107

Group type: COMPARATOR
Intervention: Traditional teaching
Number of subjects: 107
Study: 33980397

Group type: EXPERIMENTAL
Intervention: Intervention (interpersonal communication)
Number of subjects: 3786

Group type: COMPARATOR
Intervention: Control
Number of subjects: 3786
Study: 34968218

Group type: EXPERIMENTAL
Intervention: Nurse-led complex intervention
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 63
Study: 33848232

Group type: EXPERIMENTAL
Intervention: IPV-bOPV-bOPV
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: IPV-IPV-tOPV
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: IPV-IPV-bOPV
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Combined sequential vaccination schedule of IPV and bOPV
Number of subjects: 1200
Study: 33356044

Group type: EXPERIMENTAL
Intervention: Yihechun Capsules (YHC) + Levocarnitine (LC)
Number of subjects: 181

Group type: COMPARATOR
Intervention: Levocarnitine (LC)
Number of subjects: 181
Study: 33497514

Group type: EXPERIMENTAL
Intervention: Microneedling combined with NB‐UVB phototherapy and topical latanoprost 0.005%
Number of subjects: 50

Group type: COMPARATOR
Intervention: Microneedling combined with NB‐UVB phototherapy
Number of subjects: 50
Study: 36173222

Group type: EXPERIMENTAL
Intervention: Low-Carbohydrate Diet (LCD)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Low-Fat Diet (LFD)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Health Education (HE)
Number of subjects: 90
Study: 34146102

Group type: EXPERIMENTAL
Intervention: Phytase supplementation at 187.5 FYT/kg feed
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Phytase supplementation at 375 FYT/kg feed
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control diet (no phytase)
Number of subjects: 90
Study: 36237565

Group type: COMPARATOR
Intervention: Triple therapy (omeprazole, amoxicillin, and clarithromycin) for 14 days
Number of subjects: 603

Group type: EXPERIMENTAL
Intervention: Quadruple therapy (omeprazole, amoxicillin, clarithromycin, and metronidazole) for 14 days
Number of subjects: 603
Study: 33616000

Group type: EXPERIMENTAL
Intervention: Neuromuscular training group (n=22)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (n=23)
Number of subjects: 45
Study: 34493289

Group type: EXPERIMENTAL
Intervention: Health warning
Number of subjects: 1235

Group type: EXPERIMENTAL
Intervention: Combined health and environment warning
Number of subjects: 1235

Group type: EXPERIMENTAL
Intervention: Environment warning
Number of subjects: 1235

Group type: COMPARATOR
Intervention: No-label control
Number of subjects: 1235
Study: 32406569

Group type: EXPERIMENTAL
Intervention: Loop Drainage (LD)
Number of subjects: 238

Group type: COMPARATOR
Intervention: Incision and Drainage (I&D)
Number of subjects: 238
Study: 35416973

Group type: EXPERIMENTAL
Intervention: Multidose metronidazole 500 mg twice daily for 7 days
Number of subjects: 3700000

Group type: COMPARATOR
Intervention: Single-dose oral metronidazole 2 g
Number of subjects: 3700000
Study: 33719164

Group type: EXPERIMENTAL
Intervention: Intraoperative cell salvage and autotransfusion (ICSA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (without ICSA)
Number of subjects: 0
Study: 32776828

Group type: EXPERIMENTAL
Intervention: Testosterone enanthate 200 mg/week (TEST)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Testosterone enanthate (TEST)
Number of subjects: 50
Study: 35101120

Group type: EXPERIMENTAL
Intervention: Bankart repair + Remplissage
Number of subjects: 82

Group type: COMPARATOR
Intervention: Latarjet procedure
Number of subjects: 82
Study: 33106629

Group type: EXPERIMENTAL
Intervention: left prefrontal cortex anodal transcranial direct current stimulation (tDCS) with decision‐making training
Number of subjects: 133

Group type: COMPARATOR
Intervention: control groups (three control groups)
Number of subjects: 133
Study: 34819329

Group type: EXPERIMENTAL
Intervention: PEP flute self-care
Number of subjects: 378

Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 378
Study: 33239870

Group type: EXPERIMENTAL
Intervention: Novel Muscle Training Device (NMT)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Conventional Rehabilitation Training (CRT)
Number of subjects: 32
Study: 33273042

Group type: EXPERIMENTAL
Intervention: Triple therapy with metformin, pioglitazone, and exenatide
Number of subjects: 318

Group type: COMPARATOR
Intervention: Conventional therapy with sequential addition of metformin, glipizide, and insulin
Number of subjects: 318

Group type: EXPERIMENTAL
Intervention: Triple therapy
Number of subjects: 318

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 318
Study: 33228572

Group type: EXPERIMENTAL
Intervention: MINISTOP 2.0 app (6-month parent-oriented smartphone intervention)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Routine child health care (Control)
Number of subjects: 500
Study: 35768027

Group type: EXPERIMENTAL
Intervention: Urologists' recommendations (79% surgery)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Radiation oncologists' recommendations (68% radiation)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Discordant recommendations (urologists recommended surgery, radiation oncologists recommended radiation and surgery as equally appropriate)
Number of subjects: 108
Study: 32506088

Group type: EXPERIMENTAL
Intervention: Intravenous injection paracetamol (1gm) and 0.25% bupivacaine (total 20ml) in scalp block
Number of subjects: 40

Group type: COMPARATOR
Intervention: 100ml normal saline infusion and 0.25% bupivacaine (20ml) in scalp block
Number of subjects: 40
Study: 34428254

Group type: EXPERIMENTAL
Intervention: Default nudge (affirmative answer pre-selected)
Number of subjects: 1227

Group type: EXPERIMENTAL
Intervention: Social norm nudge (stated that most people answered affirmative)
Number of subjects: 1227

Group type: EXPERIMENTAL
Intervention: Default nudge (in actual choice setting)
Number of subjects: 1227

Group type: EXPERIMENTAL
Intervention: Default nudge with explanation
Number of subjects: 1227

Group type: EXPERIMENTAL
Intervention: Nudged (actual choice setting)
Number of subjects: 1227

Group type: COMPARATOR
Intervention: Control (no nudge)
Number of subjects: 1227
Study: 32358504

Group type: EXPERIMENTAL
Intervention: Blood cis-eGenes identified through Mendelian randomization (MR)
Number of subjects: 31684

Group type: EXPERIMENTAL
Intervention: Blood eGenes enriched in dendritic cells (DCs)
Number of subjects: 31684

Group type: EXPERIMENTAL
Intervention: Mendelian randomization analysis
Number of subjects: 31684
Study: 33484138

Group type: EXPERIMENTAL
Intervention: 0 risk factors present
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: 1 risk factor present
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: 2 or more risk factors present
Number of subjects: 130
Study: 34286416

Group type: EXPERIMENTAL
Intervention: Interviewer-led telephone administration of EORTC QLQ-C30
Number of subjects: 63

Group type: COMPARATOR
Intervention: Paper first administration of EORTC QLQ-C30
Number of subjects: 63

Group type: COMPARATOR
Intervention: Phone first administration of EORTC QLQ-C30
Number of subjects: 63
Study: 32307560

Group type: EXPERIMENTAL
Intervention: 20 mg of methylphenidate (N=29)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (N=31)
Number of subjects: 60
Study: 35928033

Group type: EXPERIMENTAL
Intervention: PfSPZ-CVac (CQ)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Normal saline (Control)
Number of subjects: 62
Study: 32428840

Group type: EXPERIMENTAL
Intervention: Hypoenergetic diet with 12 hours of fasting daily
Number of subjects: 58

Group type: COMPARATOR
Intervention: Hypoenergetic diet only
Number of subjects: 58
Study: 34196698

Group type: EXPERIMENTAL
Intervention: M1-rTMS
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: DLPFC-rTMS
Number of subjects: 152

Group type: COMPARATOR
Intervention: Sham-rTMS
Number of subjects: 152
Study: 32126576

Group type: EXPERIMENTAL
Intervention: EUS-guided coil embolization and cyanoacrylate injection
Number of subjects: 60

Group type: COMPARATOR
Intervention: EUS-guided coil embolization alone
Number of subjects: 60
Study: 36368940

Group type: EXPERIMENTAL
Intervention: PcV 800 mg × 4 for 5 days
Number of subjects: 433

Group type: COMPARATOR
Intervention: PcV 1 g × 3 for 10 days
Number of subjects: 433
Study: 34074585

Group type: EXPERIMENTAL
Intervention: Anakinra
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tocilizumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Baricitinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dexamethasone
Number of subjects: 0
Study: 32375100

Group type: EXPERIMENTAL
Intervention: Smart Moms intervention (mobile phone-based program)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 51
Study: 35193654

Group type: EXPERIMENTAL
Intervention: L-carnitine (3000 mg/day for 7 days)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (same dosage and duration as L-carnitine)
Number of subjects: 60
Study: 32918899

Group type: EXPERIMENTAL
Intervention: Normobaric hypoxic air (Fio2, 15%)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Ambient air (normoxia; Fio2, 21%)
Number of subjects: 28